Published in West J Med on August 01, 1986
The optimal management of mushroom poisoning remains undetermined. West J Med (2000) 0.90
Mushroom poisoning due to amatoxin. Northern California, Winter 1996-1997. West J Med (1998) 0.89
Lepiota subincarnata J.E. Lange induced fulminant hepatic failure presenting with pancreatitis. J Med Toxicol (2010) 0.78
Fulminant hepatic failure. West J Med (1988) 0.75
Treatment of mushroom amanitin poisoning. West J Med (1986) 0.75
Amatoxins, phallotoxins, phallolysin, and antamanide: the biologically active components of poisonous Amanita mushrooms. CRC Crit Rev Biochem (1978) 3.33
Amanita phalloides-type mushroom poisoning. West J Med (1982) 2.26
Earlier charcoal haemoperfusion in fulminant hepatic failure. Lancet (1982) 1.97
Clinical pharmacokinetics of oral activated charcoal in acute intoxications. Clin Pharmacokinet (1983) 1.89
Diagnosis and treatment of Amanita phalloides-type mushroom poisoning: use of thioctic acid. West J Med (1976) 1.36
New aspects of amanita poisoning. Klin Wochenschr (1979) 1.27
Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure. Gut (1982) 1.25
A new look at an old problem: mushroom poisoning. Clinical presentations and new therapeutic approaches. Am J Med (1975) 1.03
Silybin inhibition of amatoxin uptake in the perfused rat liver. Arzneimittelforschung (1980) 0.94
RENAL TUBULAR NECROSIS CAUSED BY MUSHROOM POISONING. RENAL BIOPSY FINDINGS BY ELECTRON MICROSCOPY AND USE OF PERITONEAL DIALYSIS IN TREATMENT. Arch Intern Med (1964) 0.89
Orthotopic liver transplantation in a patient with Amanita poisoning. JAMA (1985) 0.88
A rapid radioimmunoassay, using a nylon support, for amatoxins from Amanita mushrooms. Toxicon (1982) 0.86
Toxicokinetics of labeled amatoxins in the dog. Arch Toxicol (1985) 0.85
Thioctic acid in treatment of hepatotoxic mushroom (Phalloides) poisoning. N Engl J Med (1979) 0.85
Thioctic Acid and mushroom poisoning. Science (1975) 0.84
Amanita phalloides poisoning treated by early charcoal haemoperfusion. Br Med J (1978) 0.81
Histologic changes in the liver biopsy in Amanita phalloides intoxication. Hum Pathol (1972) 0.81
[The determination of amanitines in the serum of patients poisoned by amanita phalloides (author's transl)]. Nouv Presse Med (1977) 0.80
[Therapy of Amanita phalloides poisoning. Improvement of the prognosis due to interruption of the enterohepatic circulation (common bile duct drainage)]. Dtsch Med Wochenschr (1973) 0.80
A trend in the therapy of Amanita phalloides poisoning. Arch Toxicol (1976) 0.79
Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group. Neurology (1998) 3.62
Factors influencing bone lead concentration in a suburban community assessed by noninvasive K x-ray fluorescence. JAMA (1994) 2.72
Patient notification and follow-up of abnormal test results. A physician survey. Arch Intern Med (1996) 2.42
Amanita phalloides-type mushroom poisoning. West J Med (1982) 2.26
Occupational illness: case detection by poison control surveillance. Ann Intern Med (1989) 2.12
Health care cost effects of public use of a regional poison control center. West J Med (1995) 1.89
Diaphragmatic disruption secondary to blunt abdominal trauma. J Trauma (1981) 1.83
Blunt cardiac rupture. J Trauma (1984) 1.72
Drosophila coracle, a member of the protein 4.1 superfamily, has essential structural functions in the septate junctions and developmental functions in embryonic and adult epithelial cells. Mol Biol Cell (1998) 1.71
Population pharmacokinetics of fluconazole in young infants. Antimicrob Agents Chemother (2008) 1.68
Use of endogenous, stable lead isotopes to determine release of lead from the skeleton. Environ Health Perspect (1996) 1.62
Monoclonal idiotope vaccine against Streptococcus pneumoniae infection. Science (1984) 1.59
A Web-based diabetes care management support system. Jt Comm J Qual Improv (2001) 1.59
Randomized study of the treatment of phenobarbital overdose with repeated doses of activated charcoal. JAMA (1984) 1.58
Mechanisms of inhibition of tolbutamide metabolism: phenylbutazone, oxyphenbutazone, sulfaphenazole. Clin Pharmacol Ther (1977) 1.49
Metacarpophalangeal analysis in Crouzon syndrome: additional evidence for phenotypic convergence with the acrocephalosyndactyly syndromes. Am J Med Genet (1997) 1.47
Metformin overdose-induced hypoglycemia in the absence of other antidiabetic drugs. Clin Toxicol (Phila) (2013) 1.44
The dopamine transporter gene and Parkinson's disease in a Chinese population. Neurology (1997) 1.43
Occupationally related illness reported to a regional poison control center. Am J Public Health (1986) 1.40
Management of theophylline overdose patients in the intensive care unit. Anaesth Intensive Care (1992) 1.39
Underreporting of fatal cases to a regional poison control center. West J Med (1995) 1.37
Altered methadone pharmacokinetics in methadone-maintained pregnant women. J Pharmacol Exp Ther (1985) 1.35
Relationship between phenytoin and tolbutamide hydroxylations in human liver microsomes. Br J Clin Pharmacol (1991) 1.34
Surveillance of poisoning and drug overdose through hospital discharge coding, poison control center reporting, and the Drug Abuse Warning Network. Am J Emerg Med (1993) 1.32
Inadequate follow-up of abnormal mammograms. Am J Prev Med (1997) 1.31
Determination of proguanil and its metabolites cycloguanil and 4-chlorophenylbiguanide in plasma, whole blood and urine by high-performance liquid chromatography. J Chromatogr (1987) 1.26
A combination of intravenous and dietary docosahexaenoic acid significantly improves outcome after spinal cord injury. Brain (2007) 1.25
Patient-related risk factors that predict poor outcome after total hip replacement. Health Serv Res (1996) 1.25
Shorter duration of oral N-acetylcysteine therapy for acute acetaminophen overdose. Ann Emerg Med (2000) 1.25
Evaluation of factors potentially associated with inadequate follow-up of mammographic abnormalities. Cancer (1996) 1.24
Single dose pharmacokinetics of proguanil and its metabolites in healthy subjects. Br J Clin Pharmacol (1987) 1.23
Failure of haemoperfusion and haemodialysis to prevent death in paraquat poisoning. A retrospective review of 42 patients. Med Toxicol Adverse Drug Exp (1988) 1.23
Conversion of irinotecan (CPT-11) to its active metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), by human liver carboxylesterase. Biochem Pharmacol (1996) 1.18
A scanning electron microscopic study of secondary lamellae and chloride cells of rainbow trout (Salmo gairdneri). Z Zellforsch Mikrosk Anat (1973) 1.16
The costs and outcomes of restricting public access to poison control centers. Results from a natural experiment. Med Care (1998) 1.16
Environmental and drug-induced hyperthermia. Pathophysiology, recognition, and management. Emerg Med Clin North Am (1984) 1.16
Experience with 732 acute overdose patients admitted to an intensive care unit over six years. Med J Aust (1993) 1.12
Orthotopic liver transplantation in patients with cystic fibrosis. Pediatrics (1987) 1.12
Identification and properties of a major plasma metabolite of irinotecan (CPT-11) isolated from the plasma of patients. Cancer Res (1996) 1.11
The epidemiology of Parkinson's disease in an Australian population. Neuroepidemiology (1998) 1.08
Methodological considerations for the accurate determination of lead in human plasma and serum. Am J Ind Med (1998) 1.07
Effects of ethanol ingestion on the severity and outcome of trauma. Am J Surg (1982) 1.07
First-pass elimination. Basic concepts and clinical consequences. Clin Pharmacokinet (1984) 1.06
Value of rapid screening for acetaminophen in all patients with intentional drug overdose. Ann Emerg Med (1989) 1.06
Factors affecting mortality in pelvic fractures. J Trauma (1982) 1.06
Potential pitfalls in the evaluation of the usefulness of hemodialysis for the removal of lithium. J Toxicol Clin Toxicol (1982) 1.05
Hyperbaric oxygen for carbon monoxide poisoning: does it really work? Ann Emerg Med (1995) 1.05
A field evaluation of the Esophageal Obturator Airway. J Trauma (1983) 1.03
Combined evidence-based literature analysis and consensus guidelines for stocking of emergency antidotes in the United States. Ann Emerg Med (2000) 1.02
High-performance liquid chromatography of proguanil, cycloguanil and 4-chlorophenylbiguanide using hydrophobic pairing ion and its application to serum assay. J Chromatogr (1980) 1.02
The cost-effectiveness of different management strategies for patients on chronic warfarin therapy. J Gen Intern Med (2000) 1.02
Light chain isotypes selectively associate with heavy chain idiotypes in T-dependent and T-independent dextran-specific precursors. Nature (1981) 0.98
Influence of race, tobacco use, and caffeine use on the relation between blood pressure and blood lead concentration. Am J Epidemiol (1990) 0.98
Diuresis, dialysis, and hemoperfusion. Indications and benefits. Emerg Med Clin North Am (1984) 0.97
Immediate external fixation of unstable pelvic fractures. Am J Surg (1985) 0.96
Willingness to pay for poison control centers. J Health Econ (1997) 0.95
Serum formate concentrations in methanol intoxication as a criterion for hemodialysis. Ann Intern Med (1986) 0.95
The primary B cell response to the O/core region of bacterial lipopolysaccharide is restricted to the Ly-1 lineage. J Immunol (1991) 0.94
Technetium-99m NGA functional hepatic imaging: preliminary clinical experience. J Nucl Med (1985) 0.94
Toxicologic studies in a fatal overdose of 2,4-D, MCPP, and chlorpyrifos. J Anal Toxicol (1983) 0.93
Stable isotope labeling of lead compartments in rats with ultralow lead concentrations. Environ Res (1992) 0.93
Anticoagulation clinics and patient self-testing for patients on chronic warfarin therapy: A cost-effectiveness analysis. J Thromb Thrombolysis (2000) 0.93
Emergency department thoracotomy. Ann Emerg Med (1982) 0.93
Mutational alteration of the breakage/resealing subunit of bacteriophage T4 DNA topoisomerase confers resistance to antitumor agent m-AMSA. Mol Gen Genet (1990) 0.93
The subtle facial signs of prenatal exposure to alcohol: an anthropometric approach. J Pediatr (2001) 0.93
Role of repeated oral doses of activated charcoal in clinical toxicology. Med Toxicol (1986) 0.92
Incorrect overdose management advice in the Physicians' Desk Reference. Ann Emerg Med (1997) 0.92
Emergency thoracotomy in the management of trauma. JAMA (1983) 0.92
The association between polymorphisms in the cytochrome P-450 2D6 gene and Parkinson's disease: a case-control study and meta-analysis. J Neurol Sci (1997) 0.92
Rational design and application of idiotope vaccines. Int Rev Immunol (1986) 0.92
B-type natriuretic peptide concentrations to guide treatment of patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed (2008) 0.92
Carbon monoxide poisoning: mechanisms, presentation, and controversies in management. J Emerg Med (1984) 0.91
Hypotension-induced post-traumatic necrosis of the right colon. Am J Surg (1983) 0.91
A nontoxic, idiotope vaccine against gram-negative bacterial infections. J Immunol (1992) 0.90
Idiotope vaccine against Streptococcus pneumoniae. A precursor study. J Immunol (1987) 0.90
Large scale production and purification of paraquat and desipramine monoclonal antibodies and their Fab fragments. Int J Immunopharmacol (1988) 0.89
Purification and characterization of two human liver carboxylesterases. Int J Biochem (1989) 0.89
"Profiting" from vegetables. J Toxicol Clin Toxicol (1996) 0.89
Mushroom poisoning due to amatoxin. Northern California, Winter 1996-1997. West J Med (1998) 0.89
Phenytoin-induced methadone withdrawal. Ann Intern Med (1981) 0.89
Effects of nifedipine on psychosis and tardive dyskinesia in schizophrenic patients. J Clin Psychopharmacol (1991) 0.89
Orthotopic liver transplantation in a patient with Amanita poisoning. JAMA (1985) 0.88
Removal of theophylline from the body by haemoperfusion. Clin Pharmacokinet (1979) 0.88
Albumin enhances unidirectional fluxes of fatty acid across a lipid-water interface: theory and experiments. Am J Physiol (1989) 0.87
CPR-only survivors of out-of-hospital cardiac arrest: implications for out-of-hospital care and cardiac arrest research methodology. Ann Emerg Med (2001) 0.87
Quantitative analysis of two pyridinium metabolites of haloperidol in patients with schizophrenia. Clin Pharmacol Ther (1994) 0.87
Peritoneal lavage and angiography in the management of patients with pelvic fractures. Am J Surg (1982) 0.87
Presystemic metabolism of meperidine to normeperidine in normal and cirrhotic subjects. Clin Pharmacol Ther (1981) 0.87
Analysis of the immune response to lipopolysaccharide. Existence of an interspecies cross-reactive idiotype associated with anti-lipid A antibodies. J Immunol (1990) 0.86
Using neural networks to identify patients unlikely to achieve a reduction in bodily pain after total hip replacement surgery. Med Care (1997) 0.86
Effects of a major earthquake on calls to regional poison control centers. West J Med (1992) 0.86
Blood and extracellular fluid volume in whole body and tissues of the Pacific hagfish, Eptatretus stouti. Physiol Biochem Zool (2001) 0.85
Single dose pharmacokinetics of proguanil and its metabolites in pregnancy. Eur J Clin Pharmacol (1993) 0.85
Activation of the food-derived mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by rabbit and human liver microsomes and purified forms of cytochrome P-450. Carcinogenesis (1989) 0.85